LEADER 03376nam  2200577Ia 450 
001 9910830931203321
005 20230828225253.0
010   $a1-280-74319-0
010   $a9786610743193
010   $a0-470-79480-1
010   $a0-470-99474-6
010   $a1-4051-7253-3
035   $a(CKB)1000000000342165
035   $a(EBL)284207
035   $a(OCoLC)85822919
035   $a(SSID)ssj0000169741
035   $a(PQKBManifestationID)11153740
035   $a(PQKBTitleCode)TC0000169741
035   $a(PQKBWorkID)10203680
035   $a(PQKB)11605365
035   $a(MiAaPQ)EBC284207
035   $a(EXLCZ)991000000000342165
100   $a20060109d2006      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aHeart failure$b[electronic resource] $epharmacologic management /$fedited by Arthur M. Feldman
210   $aOxford $cBlackwell Futura$d2006
215   $a1 online resource (306 p.)
300   $aDescription based upon print version of record.
311   $a1-4051-0361-2 
320   $aIncludes bibliographical references.
327   $aHeart Failure: Pharmacologic Management; Contents; Contributors; Introduction; 1 Diuretics in congestive heart failure; 2 Use of digoxin in the treatment of heart failure; 3 Renin-angiotensin system and angiotensin converting enzyme inhibitors in chronic heart failure; 4 Angiotensin receptor blockers in the treatment of heart failure; 5 Beta blockers; 6 Aldosterone antagonism in the pharmacological management of chronic heart failure; 7 Inotropic therapy in clinical practice; 8 Antiarrhythmic therapy in heart failure
327   $a9 Treating the hypercoagulable state of heart failure: modifying the risk of arterial and venous thromboembolism10 Vasodilator and nitrates; 11 Natriuretic peptides for the treatment of heart failure; 12 Immune modulatory therapies in heart failure: using myocarditis to gain mechanistic insights; 13 The role of vasopressin and vasopressin antagonists in heart failure; 14 Role of erythropoietin in the correction of anemia in patients with heart failure; 15 Endothelin antagonism in cardiovascular disease; 16 Pharmacogenetics; 17 Management of diastolic dysfunction
327   $a18 Multidrug pharmacy for treatment of heart failure: an algorithm for the clinicianIndex
330   $aNow there is an up-to-date guide for optimizing pharmacologic therapy in treating patients with heart failure. Reflecting current practice at leading medical centers, Heart Failure: Pharmacologic Management provides both the biologic and pathologic underpinnings of each pharmacologic agent in current use. It also supplies detailed discussions of the clinical investigations that support current understanding of the risks and benefits associated with the use of these drugs. Thorough references make the book useful to the novice as well as the experienced clinician. Initial cha
606   $aCongestive heart failure$xChemotherapy
606   $aHeart
615  0$aCongestive heart failure$xChemotherapy.
615  0$aHeart.
676   $a616.129061
701   $aFeldman$b Arthur M$g(Arthur Michael),$f1949-$01343629
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910830931203321
996   $aHeart failure$93067887
997   $aUNINA